T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Hackett Group
HCKT
$277M
| $417K | ﹤0.01% |
30,090
+11,770
| +64% | +$172K |
|
2027
Thomson Reuters
TRI
$46B
| $417K | ﹤0.01% |
8,930
-37
| -0.4% | -$1.76K |
|
2028
Caesars Entertainment
CZR
$6.04B
| $415K | ﹤0.01% |
27,318
| – | – |
|
|
EBIX
2029
DELISTED
Ebix Inc
EBIX
| $415K | ﹤0.01% |
8,672
-2,100
| -19% | -$96.5K |
|
|
PRO
2030
DELISTED
PROS Holdings
PRO
| $414K | ﹤0.01% |
23,760
| – | – |
|
|
NRE
2031
DELISTED
NorthStar Realty Europe Corp.
NRE
| $414K | ﹤0.01% |
44,760
-11,039
| -20% | -$124K |
|
2032
Peapack-Gladstone Financial
PGC
$822M
| $412K | ﹤0.01% |
22,237
+1,000
| +5% | +$18.4K |
|
2033
SPX Corp
SPXC
$10.6B
| $412K | ﹤0.01% |
27,735
+32
| +0.1% | +$507 |
|
2034
Bank of America Series L
BAC.PRL
$4.01B
| $405K | ﹤0.01% |
340
+103
| +43% | +$121K |
|
2035
Motorcar Parts of America
MPAA
$235M
| $404K | ﹤0.01% |
14,850
+2,600
| +21% | +$81.7K |
|
|
WWE
2036
DELISTED
World Wrestling Entertainment
WWE
| $403K | ﹤0.01% |
21,900
+6,500
| +42% | +$113K |
|
|
ACRE
2037
Ares Commercial Real Estate
ACRE
$264M
| $400K | ﹤0.01% |
32,584
-16
| -0% | -$189 |
|
|
MCHB
2038
Mechanics Bancorp
MCHB
$3.79B
| $400K | ﹤0.01% |
20,074
+4,974
| +33% | +$104K |
|
2039
E.W. Scripps
SSP
$310M
| $400K | ﹤0.01% |
25,232
-9,214
| -27% | -$147K |
|
2040
Toyota
TM
$223B
| $400K | ﹤0.01% |
4,000
| – | – |
|
|
SCTY
2041
DELISTED
SolarCity Corporation
SCTY
| $400K | ﹤0.01% |
16,727
-61,809
| -79% | -$1.52M |
|
2042
3D Systems Corp
DDD
$601M
| $399K | ﹤0.01% |
29,111
+105
| +0.4% | +$1.52K |
|
2043
Lindsay Corp
LNN
$1.17B
| $399K | ﹤0.01% |
5,880
| – | – |
|
2044
Koppers
KOP
$874M
| $398K | ﹤0.01% |
12,963
-37
| -0.3% | -$958 |
|
2045
Tidewater
TDW
$4.55B
| $394K | ﹤0.01% |
2,768
+434
| +19% | +$88.8K |
|
|
WMC
2046
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $393K | ﹤0.01% |
4,182
| – | – |
|
|
MTGE
2047
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $392K | ﹤0.01% |
24,823
+9,294
| +60% | +$142K |
|
2048
City Holding Co
CHCO
$2.08B
| $391K | ﹤0.01% |
8,590
| – | – |
|
2049
Global Net Lease
GNL
$1.9B
| $391K | ﹤0.01% |
16,411
+3,044
| +23% | +$76.9K |
|
2050
Delek US
DK
$4.18B
| $390K | ﹤0.01% |
29,550
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.